Induced keratinocyte hyper-proliferation in α2β1 integrin transgenic mice results in systemic immune cell activation

International Immunopharmacology

Volumn 10, Issue 1, 2010, Pages 107-114

  Teige, Ingrid ^a   Bäcklund, Alexandra ^a   Svensson, Lars ^a   Kvist, Peter Helding ^a   Petersen, Thomas Kongstad ^a   Kemp, Kåre ^a  

^a LEO Pharma   (Denmark)

Author keywords

Cytokines; Inflammation; Skin; T cells

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 2;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS HYPERPLASIA; FEMALE; IMMUNOCOMPETENT CELL; INFLAMMATORY INFILTRATE; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; SKIN INJURY; SPLEEN SIZE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WILD TYPE; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; HUMANS; INFLAMMATION; INTEGRIN ALPHA2BETA1; KERATINOCYTES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN PRECURSORS; PSORIASIS; SKIN; T-LYMPHOCYTES; WOUND HEALING;

EID: 73349126990     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.10.004     Document Type: Article

References (33)

1. Lowes M.A., Bowcock A.M., and Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 445 7130 (2007) 866-873
2. Nickoloff B.J., Bonish B.K., Marble D.J., et al. Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. J Investig Dermatol Symp Proc 11 1 (2006) 16-29
3. Gniadecki R. Regulation of keratinocyte proliferation. Gen Pharmacol 30 5 (1998) 619-622
4. Romero M.R., Carroll J.M., and Watt F.M. Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis: effects of suprabasal integrin expression on keratinocyte adhesion, proliferation and terminal differentiation. Exp Dermatol 8 1 (1999) 53-67
5. Raghavan S., Bauer C., Mundschau G., Li Q., and Fuchs E. Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol 150 5 (2000) 1149-1160
6. Hertle M.D., Kubler M.D., Leigh I.M., and Watt F.M. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 89 6 (1992) 1892-1901
7. Weiss G., Shemer A., and Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol 16 3 (2002) 241-248
8. Segaert S., and Duvold L.B. Calcipotriol cream: a review of its use in the management of psoriasis. J Derm Treat 17 6 (2006) 327-337
9. Carroll J.M., Romero M.R., and Watt F.M. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83 6 (1995) 957-968
10. Bovenschen H.J., Seyger M.M., and Van De Kerkhof P.C. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153 1 (2005) 72-78
11. Onuma S. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 21 4 (1994) 223-232
12. Nickoloff B.J., Xin H., Nestle F.O., and Qin J.Z. The cytokine and chemokine network in psoriasis. Clin Dermatol 25 6 (2007) 568-573
13. Abul H., Mahmoud F., Al Saleh Q., Khajeji M., and Haines D. Profiles of activated T lymphocytes in peripheral blood of Kuwaiti psoriasis vulgaris patients. J Dermatol 29 4 (2002) 202-208
14. Ferenczi K., Burack L., Pope M., Krueger J.G., and Austin L.M. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun 14 1 (2000) 63-78
15. Paukkonen K., Naukkarinen A., and Horsmanheimo M. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res 287 2 (1995) 165-170
16. Haase I., Hobbs R.M., Romero M.R., Broad S., and Watt F.M. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108 4 (2001) 527-536
17. Ghoreschi K., Weigert C., and Rocken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 25 6 (2007) 574-580
18. Marcatili A., Cipollaro D.L., Galdiero M., Folgore A., and Petrillo G. TNF-alpha, IL-1 alpha, IL-6 and ICAM-1 expression in human keratinocytes stimulated in vitro with Escherichia coli heat-shock proteins. Microbiology 143 Pt 1 (1997) 45-53
19. Teunissen M.B., Koomen C.W., de Waal M.R., Wierenga E.A., and Bos J.D. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111 4 (1998) 645-649
20. Lecewicz-Torun B., Pietrzak A., and Rolinski J. The correlation between activity and a circulating lymphocyte pattern in plasma of patients with psoriasis preceded by an infection. Ann Univ Mariae.Curie.Sklodowska.[Med] 54 (1999) 269-276
21. Pietrzak A., Podhorecka M., Chodorowska G., et al. IL-6 and FAS (CD95) serum level in patients suffering from psoriasis and in relation to the lymphocyte subpopulations. Ann Univ Mariae.Curie.Sklodowska.[Med] 59 1 (2004) 500-504
22. Krueger J.G., and Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64 Suppl 2 (2005) ii30-ii36
23. Boehncke W.H., Zollner T.M., Dressel D., and Kaufmann R. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model. J Cutan Pathol 24 1 (1997) 1-7
24. Nickoloff B.J., and Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155 1 (1999) 145-158
25. Bovenschen H.J., Vissers W.H., Seyger M.M., and Van De Kerkhof P.C. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment. Acta Derm Venereol 85 2 (2005) 113-117
26. Kohlmann W.M., Urban W., Sterry W., and Foerster J. Correlation of psoriasis activity with abundance of CD25+CD8+ T cells: conditions for cloning T cells from psoriatic plaques. Exp Dermatol 13 10 (2004) 607-612
27. Vissers W.H., Arndtz C.H., Muys L., Van Erp P.E., de Jong E.M., and Van De Kerkhof P.C. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 150 5 (2004) 852-859
28. Boyman O., Conrad C., Dudli C., Kielhorn E., Nickoloff B.J., and Nestle F.O. Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol 152 6 (2005) 1211-1218
29. Boyman O., Conrad C., Tonel G., Gilliet M., and Nestle F.O. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol 28 2 (2007) 51-57
30. Nestle F.O., Turka L.A., and Nickoloff B.J. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 94 1 (1994) 202-209
31. Nestle F.O., Conrad C., Tun-Kyi A., et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202 1 (2005) 135-143
32. Gudjonsson J.E., and Elder J.T. Psoriasis: epidemiology. Clin Dermatol 25 6 (2007) 535-546
33. Paukkonen K., Naukkarinen A., and Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8 + T cells and CD11c + macrophages into the epidermis. Arch Dermatol Res 284 7 (1992) 375-379